AB0597 Low-Dose Rituximab as Induction Therapy for Japanese Patients With Anca-Associated Vasculitis

doi 10.1136/annrheumdis-2017-eular.5410

Full Text

Abstract

Available in

Date

June 1, 2017

Authors

Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports

English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Clinical Journal of the American Society of Nephrology

Transplantation

Intensive Care Medicine

English

Anca-Associated Vasculitis

The Journal of scientific articles Health and Education millennium

English

Rheumatoid Arthritis With ANCA Associated Vasculitis

Internet Journal of Rheumatology and Clinical Immunology

English

Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab

BMJ Case Reports

English

Psy4 - Response to Induction Therapy, Treatment Adverse Events and Healthcare Resource Use in Incident Anca-Associated Vasculitis (Aav) Patients

Value in Health

Occupational Health

English

SAT0527 Rituximab Prescription Patterns and Efficacy in the Induction Treatment of Anca-Associated Vasculitis in a Belgian Multicentric Cohort

English

Genetics of ANCA-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

English